• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Jiaqiang,WEI Tingting,YANG Wenzhi.Consideration of pharmaceutical study for the generic drugs of ophthalmic suspension[J].Journal Of Pharmaceutical Research,2024,43(9):876-879[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3436times   Download 3582次 QR Code for this article
Scan with your phone!
混悬型滴眼剂仿制药药学研究的相关考虑
王家强,魏婷婷,杨文智
Font:Larger+|Default|Smaller-
(国家药品监督管理局药品审评中心,北京 100076)
摘要:
混悬型滴眼剂系指难溶性固体药物以微粒状态分散于介质中形成的无菌眼用液体制剂。本文从化学药品仿制药混悬型滴眼剂的处方、生产工艺、质量研究、包材和稳定性研究等药学方面问题进行了初步的探讨,汇总了国内外文献中混悬型滴眼剂开发过程中关键研究指标,以助于业界对混悬型滴眼剂仿制药的开发。
关键词:  混悬型滴眼剂  仿制药  药学研究
DOI:10.13506/j.cnki.jpr.2024.09.008
基金项目:
Publication Date:September 25, 2024
Consideration of pharmaceutical study for the generic drugs of ophthalmic suspension
WANG Jiaqiang,WEI Tingting,YANG Wenzhi
(Center For Drug Evaluation, National Medical Products Administration, Beijing 100076, China)
Abstract:
Ophthalmic suspension is a sterile liquid preparation formed by dispersing insoluble solid drugs in a dispersion medium. This paper preliminarily discusses the formulation, manufacturing process, quality study, container and stability study of ophthalmic suspension, and summarizes the key study parameters of ophthalmic suspension development process from the domestic and foreign references, in order to help the industry to develop ophthalmic suspension generic drugs.
Key words:  Ophthalmic suspension  Generic drugs  Pharmaceutical study
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.